Provided by Tiger Trade Technology Pte. Ltd.

Organovo

2.04
0.0000
Volume:- -
Turnover:502.51K
Market Cap:3.64M
PE:-0.21
High:2.04
Open:2.04
Low:2.04
Close:2.04
52wk High:21.96
52wk Low:1.56
Shares:1.78M
Float Shares:1.62M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7830
EPS(LYR):-19.2513
ROE:-378.40%
ROA:-123.36%
PB:9.99
PE(LYR):-0.11

Loading ...

Company Profile

Company Name:
Organovo
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.